Teva Surges Once Again on $1.1 Billion Sale and New CEO - TheStreet
Teva continues to wobble as rival drug receives FDA approval - The Jerusalem Post
Eyal Desheh Acting President CEO Teva Pharmaceuticals Editorial Stock Photo - Stock Image | Shutterstock
TA-35 Index - Wikipedia
Teva misses on both profit and revenue in Q3 - Globes
The Tel Aviv Stock Exchange opens trading in price increases by Investing.com - time.news - Time News
UBS raises Teva price target - Globes
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Historical Intraday Market Prices | TEVA | IL0006290147 | MarketScreener
Teva is back: returned to being the largest company in terms of market value in Israel :: Israeli Financial News - The Israeli Economic World
Israel stocks lower at close of trade; TA 35 down 0.71% - GICC FX
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva's challenges mount amid search for new chief
Teva's Stock Price Surge Against Its Predictable Woes
Teva Delists From TASE, Mylan May Follow - Hamodia.com
Teva Pharmaceuticals - Wikiwand
Israel Tel Aviv Stock Exchange High Resolution Stock Photography and Images - Alamy
What's 'down' with Teva? - The Jerusalem Post
Teva will lease new 17-floor Tel Aviv HQ from Vitania - Globes
Teva shares take tumble after warning of bleak 2019 - Business - Haaretz.com
Teva slide could draw vultures but it won't be easy prey | The Times of Israel
Teva Sells Closed Factory, Land Rights in $30M Deal | The Jewish Press - JewishPress.com | Hana Levi Julian | 30 Shevat 5779 – February 4, 2019 | JewishPress.com
Israeli company Teva Pharmaceutical stocks drop nearly 18% - The Jerusalem Post
Israel Tel Aviv Stock Exchange High Resolution Stock Photography and Images - Alamy
Tel Aviv exchange sells 19.9% stake to New York-based Manikay Partners
Comeback: Teva released its reports and jumped in Tel Aviv by 18% | Israel today - The Limited Times
